NEUROD1 and diabetes mellitus: Several studies with small sample sizes (n = 25–289) [6, 7, 8] have screened NEUROD1 variants in selected patients who were suspected of having monogenic diabetes and showed a relatively high prevalence (1.5%–4%), which factually might have overestimated the prevalence of NEUROD1‐MODY.